ID   CAL-185
AC   CVCL_G081
SY   CAL 185; Centre Antoine Lacassagne-185
DR   Wikidata; Q54808387
RX   PubMed=11720483;
CC   Doubling time: 72 hours (Note=At 26th passage) (PubMed=11720483).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
RX   PubMed=11720483; DOI=10.1054/bjoc.2001.2105; PMCID=PMC2375255;
RA   Cattan, Nancy
RA   Rochet, Nathalie
RA   Mazeau, Christiane
RA   Zanghellini, Evelyne
RA   Mari, Bernard
RA   Chauzy, Claude
RA   Stora de Novion, Helene
RA   Amiel, Jeanne
RA   Lagrange, Jean-Leon
RA   Rossi, Bernard
RA   Gioanni, Jeannine
RT   "Establishment of two new human bladder carcinoma cell lines, CAL 29
RT   and CAL 185. Comparative study of cell scattering and epithelial to
RT   mesenchyme transition induced by growth factors.";
RL   Br. J. Cancer 85:1412-1417(2001).
//